Achilles Therapeutics Pl-adr logo

Achilles Therapeutics Pl-adr Share Price (NASDAQ: ACHL)

▲

-1.47

(-100%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 20 Mar 2025

Check the interactive Achilles Therapeutics Pl-adr Stock chart to analyse performance

Achilles Therapeutics Pl-adr Key Stats

Check Achilles Therapeutics Pl-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.47
Open
$1.48
Market Capitalization
$63.2M
Today's Volume
$1.2M
Revenue TTM
$0.0
EBITDA
$-67.2M
Earnings Per Share (EPS)
$-1.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-52.12%

Global Institutional Holdings in Achilles Therapeutics Pl-adr

  • Name

    Holdings %

  • Syncona Portfolio Ltd.

    26.98%

  • BML Capital Management LLC

    9.98%

  • FCPM III SERVICES BV

    5.82%

  • Redmile Group, LLC

    3.91%

  • Vestal Point Capital LP

    3.65%

  • Ikarian Capital, LLC

    3.51%

Analyst Recommendation on Achilles Therapeutics Pl-adr Stock

Rating
Trend

Buy

    70%Buy

    20%Hold

    10%Sell

Based on 10 Wall street analysts offering stock ratings for Achilles Therapeutics Pl-adr(by analysts ranked 0 to 5 stars)

About Achilles Therapeutics Pl-adr

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.
Organization
Achilles Therapeutics Pl-adr
Employees
204
CEO
Dr. Iraj Ali Ph.D.
Industry
Miscellaneous

Key Management of Achilles Therapeutics Pl-adr

NameTitle
Dr. Iraj Ali Ph.D.
CEO & Director
Dr. Sergio A. Quezada Ph.D.
Founder
Mr. Robert Coutts
Chief Financial Officer
Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Charles Swanton FMEDSCI, M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Mr. Lee M. Stern
Vice President of Investor Relations & External Communications
Mr. Daniel Carey Cazel Hood
General Counsel & Company Secretary
Julia Wilson
Head of Communications
Mr. Tariq Ahmed
Executive Vice President of People

Important FAQs about investing in ACHL Stock from India :

What is Achilles Therapeutics Pl-adr share price today?

Achilles Therapeutics Pl-adr share price today is as on . Achilles Therapeutics Pl-adr share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Achilles Therapeutics Pl-adr share?

Achilles Therapeutics Pl-adr share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Achilles Therapeutics Pl-adr stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Achilles Therapeutics Pl-adr Stock (ACHL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Achilles Therapeutics Pl-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Achilles Therapeutics Pl-adr Shares .

What is the minimum amount required to buy Achilles Therapeutics Pl-adr Stock (ACHL) from India?

Indian investors can start investing in Achilles Therapeutics Pl-adr (ACHL) shares with as little as ₹91.127 or $1 (as of February 20, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹911.27 in Achilles Therapeutics Pl-adr stock (as per the Rupee-Dollar exchange rate as on February 20, 2026). Learn more about fractional shares .

What are the returns that Achilles Therapeutics Pl-adr has given to Indian investors in the last 5 years?

Achilles Therapeutics Pl-adr stock has given 0.0% share price returns and 25.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?